The Association of Senegalese Medical Equipment Professionals (Aspem) has warned that the national health sector faces a potential decline in technical capacity due to unpaid debts exceeding 10 billion CFA francs. During a press conference held in Dakar on July 4, Harouna Keïta stated that over 20 member companies are struggling with payment delays of up to three years, forcing many to rely on bank credit to remain operational.
Did You Know?
While the identified debt from over 20 companies exceeds 10 billion CFA francs, Harouna Keïta suggests that when accounting for all actors across the medical equipment sector, the total outstanding debt is likely higher.
Why the medical supply sector is at a breaking point
According to Aspem, the current financial situation is unsustainable for businesses that supply public health structures. Companies are currently waiting between one and three years to receive payment for delivered goods, a delay that Harouna Keïta says severely compromises their ability to invest. This liquidity crisis forces these businesses to seek bank loans, which weakens their financial situation.
How administrative hurdles impact health services
Beyond financial debts, the association reports that excessive administrative constraints are hindering the delivery of medical products. Specifically, the group pointed to delays at the Senegalese Agency for Pharmaceutical Regulation (Arp) regarding import authorizations. According to the association, procedures intended to last a few days often stretch into weeks or months. These bottlenecks frequently cause goods to remain stuck in customs, leading to increased storage fees and, in some instances, the expiration of sensitive medical products before their commercialization.
Expert Insight:
The situation highlights a tension between Senegal’s drive for health sovereignty and the administrative and fiscal realities facing local providers. The reliance on bank credit to cover state-run payment gaps creates a vulnerability, where the financial health of private suppliers directly dictates the quality and availability of the national medical plateau. If these payment and regulatory cycles are not streamlined, the shift toward local production may be stifled by these operational inefficiencies.
What may happen next
The association is calling for the state to implement a sustainable plan to clear existing debts and guarantee future payment timelines. While the current outlook remains tense, the sector has expressed some optimism regarding the recent adoption of the law on factoring. Members of Aspem suggest that this legal framework could provide a path to recover debts from public establishments more efficiently. Furthermore, if the government moves to revise taxes and customs duties on medical equipment and spare parts, it could provide the necessary support for the growing number of local firms now investing in the production of medical consumables, pharmaceuticals, and medical gases.
Frequently Asked Questions
What is the primary cause of the current crisis according to Aspem?
The primary cause is the accumulation of unpaid debts by public health structures, which now exceeds 10 billion CFA francs, combined with extended payment delays and fiscal and customs pressure.
What impact do these delays have on local medical companies?
These delays force companies to rely on bank credit, which weakens their financial situation and limits their capacity for investment.
Are there any signs of progress for the sector?
Yes, the association has publicly welcomed the adoption of the law on factoring, which they believe could help companies recover their claims on public establishments more rapidly.
How do you believe the government should balance the need for fiscal oversight with the urgent requirement for reliable medical supply chains in public hospitals?
